Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake

Nucleic Acids Research

Volumn 27, Issue 15, 1999, Pages 3159-3167

  Bramlage, Birgit ^a   Alefelder, Stefan ^a,b   Marschall, Peter ^a,c   Eckstein, Fritz ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FLUORESCEIN; LIPOSOME; LUCIFERASE; PHOSPHOROTHIOIC ACID; RIBOZYME;

ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CHOLESTEROL; DOWN-REGULATION; DRUG CARRIERS; FLUORESCEIN; GENES, REPORTER; HELA CELLS; HUMANS; KINETICS; LUCIFERASES; MICROSCOPY, FLUORESCENCE; NUCLEIC ACID CONFORMATION; RNA, CATALYTIC; RNA, MESSENGER; TRANSFECTION;

EID: 0033178274     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/27.15.3159     Document Type: Article

References (48)

1. Birikh, K.R., Heaton, P.A. and Eckstein, F. (1997) Eur. J. Biochem., 245, 1-16.
2. Bramlage, B., Luzi, E. and Eckstein, F. (1998) Trends Biotechnol., 16, 434-438.
3. Rossi, J. (1998) BioDrugs, 1, 1-10.
4. Jarvis, T.C., Alby, L.J., Beaudry, A.A., Wincott, F.E., Beigelman, L., McSwiggen, J.A., Usman, N. and Stinchcomb, D.T. (1996) RNA, 2, 419-428.
5. Jarvis, T.C., Wincott, F.E., Alby, L.J., McSwiggen, J.A., Beigelman, L., Gustofson, J., Direnzo, A., Levy, K., Arthur, M., Maculic-Adamic, J., Karpeisky, A., Gonzalez, C., Woolf, T.M., Usman, N. and Stinchcomb, D.T. (1996b) J. Biol. Chem., 271, 29107-29112.
6. Scherr, M., Grez, M., Ganser, A. and Engels, J.W. (1997) J. Biol. Chem., 272, 14304-14313.
7. Sioud, M. and Sørensen, D.R. (1998) Nature Biotechnol., 16, 556-561.
8. Citti, L., Eckstein, F., Capecci, B., Mariani, L., Nevischi, S., Poggi, A. and Rainaldi, G. (1999) Antisense Nucleic Acid Drug Dev., 9, 125-133.
9. Snyder, D.S., Wu, Y., Wang, J.L., Rossi, J.J., Swiderski, P., Kaplan, B.E. and Forman, S.J. (1993) Blood, 82, 600-605.
10. Zhang, X., Yamada, R., Shimayama, T., Imada, K., Uchiyama, T. and Hattori, T. (1996) Biochem. Biophys. Res. Commun., 229, 466-471.
11. Gu, J.-L., Nadler, J. and Rossi, J. (1997) Mol. Cell. Biochem., 172, 47-57.
12. Wang, Q., Bashar, M., Hansen, C., Asundi, J. and Robishaw, J.D. (1997) J. Biol. Chem., 272, 26040-26048.
13. Kitajima, I., Hanyu, N., Soejima, Y., Hirano, R., Arahira, S., Yamaoka, S., Yamada, R., Maruyama, I. and Kaneda, Y. (1997) J. Biol. Chem., 272, 27099-27106.
14. Flores, M.V.C., Atkins, D., Wade, D., O'Sullivan, W.J. and Stewart, T.S. (1997) J. Biol. Chem., 272, 16940-16945.
15. Zhang, X., Iwatani, Y., Shimayama, T., Yamada, R., Koito, A., Xu, Y., Sakai, H., Uchiyama, T. and Hattori, T. (1998) Antisense Nucleic Acid Drug Dev., 8, 441-450.
16. Lange, W. (1995) Klin. Pädiatr., 207, 222-224.
17. Matsushita, H., Kobayashi, H., Mori, S., Kizaki, M. and Ikeda, Y. (1995) Biochem. Biophys. Res. Commun., 215, 431-437.
18. Sioud, M. (1997) Nucleic Acids Res., 25, 333-338.
19. Dorai, T., Goluboff, E.T., Olsson, C.A. and Buttyan, R. (1997) Anticancer Res., 17, 3307-3312.
20. Lyngstadaas, S.P., Risnes, S., Sproat, B.S., Thrane, P.S. and Prydz, H.P. (1995) EMBO J., 14, 5224-5229.
21. Flory, C.M., Pavco, P.A., Jarvis, T.C., Lesch, M.E., Wincott, J.E., Beigelman, L., Hunt, S.W. and Schrier, D.J. (1996) Proc. Natl Acad. Sci. USA, 93, 754-758.
22. Sioud, M. (1996) Eur. J. Immunol., 26, 1026-1031.
23. Miller, A.D. (1998) Angew. Chem. Int. Ed., 37, 1768-1785.
24. Hope, M.J., Mui, B., Ansell, S. and Ahkong, Q.F. (1998) Mol. Memb. Biol., 15, 1-14.
25. Bennett, C.F. (1998) In Stein, C.A. and Krieg, A.M. (eds), Applied Antisense Oligonucleotide Technology. Wiley-Liss, New York, pp. 129-145.
26. Clarenc, J.P., Deglos, G., Leonetti, J.P., Milhaud, P. and Lebleu, B. (1993) Anti Cancer Drug Des., 8, 81-94.
27. Shoji, Y., Ishige, H., Tamura, N., Iwatani, W., Norimatsu, M., Shimada, J. and Mizushima, Y. (1998) J. Drug Targ., 5, 261-273.
28. Letsinger, R.L., Zhang, G., Sun, D.K., Ikeuchi, T. and Sarin, P.S. (1989) Proc. Natl Acad. Sci. USA, 86, 6553-6556.
29. Stein, C.A., Pal, R., Devico, A.L., Hoke, G., Mumbauer, S., Kinstler, O., Sarnhgadharan, M.G. and Letsinger, R.L. (1991) Biochemistry, 30, 2439-2444.
30. Krieg, A.M., Tonkinson, J., Matson, S., Zhao, Q., Saxon, M., Zhang, L.-M., Bhanja, U., Yakubov, L. and Stein, C.A. (1993) Proc. Natl Acad. Sci. USA, 90, 1048-1052.
31. Zelphati, O., Wagner, E. and Leseiman, L. (1994) Antiviral Res., 25, 13-25.
32. Alahari, S.K., Dean, N.M., Fisher, M.H., Manoharan, M., Tivel, K.L. and Juliano, R.L. (1996) Mol. Pharmacol., 50, 808-819.
33. Epa, W.R., Rong, P., Bartlett, P.F., Coulson, E.J. and Barrett, G.L. (1998) Antisense Nucleic Acid Drug Dev., 8, 489-498.
34. Gossen, M. and Bujard, H. (1992) Proc. Natl Acad. Sci. USA, 89, 5547-5551.
35. Heidenreich, O., Benseler, F., Fahrenholz, A. and Eckstein, F. (1994) J. Biol. Chem. 269, 2131-2138.
36. Sigurdsson, S.Th. and Eckstein, F. (1996) Nucleic Acids Res., 24, 3129-3133.
37. Sigurdsson, S.Th., Seeger, B., Kutzke, U. and Eckstein, F. (1996) J. Org. Chem. 61, 3883-3884.
38. Aurup, H., Siebert, A., Benselet, F., Williams, D. and Eckstein, F. (1994) Nucleic Acids Res., 22, 4963-1968.
39. Maniatis, T., Fritsch, E.F. and Sambrook, J. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
40. Konopka, K., Rossi, J.J., Swiderski, P., Slepushkin, V.A. and Düzgünes, N.L. (1998) Biochem. Biophys. Acta, 1372, 55-68.
41. Prasmickaite, L., Høgset, A., Mælamdsmo, G., Berg, K., Goodchild, J., Perkins, T., Fodstad, Ø. and Hovig, E. (1998) Nucleic Acids Res., 26, 4241-4248.
42. Wingens, M., van Hooijdonk, C.A.E.M., de Jongh, G.J., Schalkwijk, J. and van Erp, P.E.J. (1998) Arch. Dermatol. Res., 290, 119-125.
43. Thierry, A.R. and Dritschilo, A. (1992) Nucleic Acids Res., 20, 5691-5698.
44. Flanagan, W. and Wagner, R.W. (1998) In Stein, C.A. and Krieg, A.M. (eds), Applied Antisense Oligonucleotide Technology. Wiley-Liss, New York, pp. 175-191.
45. Fell, P.L., Hudson, A.J., Reynolds, M.A., Usman, N. and Akhtar, S. (1997) Antisense Nucleic Acid Drug Dev., 7, 319-326.
46. Hormes, R., Homann, M., Oelze, I., Marschall, P., Tabler, M., Eckstein, F. and Sczakiel, G. (1997) Nucleic Acids Res., 25, 769-775.
47. Bertrand, E., Castanoto, D., Zhou, C., Carbonnelle, C., Lee, N.S., Good, P., Chatterjee, S., Grange, T., Pictet, R., Kohn, D., Engelke, D. and Rossi, J.J. (1997) RNA, 3, 75-88.
48. Xie, F., Chen, X. and Wagner, T.E. (1997) Proc. Natl Acad. Sci. USA, 94, 13777-13781.